Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sally Y, Barbour"'
Autor:
Michael DeCoske, Paul W. Bush, Meredith T. Moorman, Laura A Meleis, Mallika P Patel, Sally Y. Barbour
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Introduction: In recent years, there has been significant growth of ambulatory oncology pharmacy, yet there is a paucity of published studies on the clinical activities and impact of ambulatory oncology clinical pharmacists. At Duke Cancer Center, de
Autor:
Kristopher Dennis, Kimberly Noonan, Paul J. Hesketh, Dee Sparacio, Sally Y. Barbour, Stacie B. Dusetzina, Rebecca Clark-Snow, Kari Bohlke, Petra Feyer, Karin Jordan, Cathy Eng, Gary H. Lyman, L. Lee Dupuis, Ethan Basch, Michael A. Danso, Mark G. Kris
Publikováno v:
Journal of Clinical Oncology. 38:2782-2797
PURPOSE To update the guideline to include new anticancer agents, antiemetics, and antiemetic regimens and to provide recommendations on the use of dexamethasone as a prophylactic antiemetic in patients receiving checkpoint inhibitors (CPIs). METHODS
Autor:
Jennifer P Booth, Julie M Kennerly-Shah, Lindsey R Kelley, Donna Capozzi, Hillary A Prescott, Scott A Soefje, Makala B Pace, Sally Y Barbour, Ricky F Tizon, Sarah DeVincenzo, Cynthia A Carnes, Marjorie V Neidecker
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311576
Introduction Prioritization and acuity tools have been leveraged to facilitate targeted and efficient clinical pharmacist interventions. However, there is a lack of established pharmacy-specific acuity factors in the ambulatory hematology/oncology se
Autor:
Sally Y. Barbour
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Sally Barbour, PharmD, BCOP, CPP, FHOPA, updated attendees on the FDA-approved therapies for initial or expanded indications for solid tumors across the past year, as well as their supporting clinical trial data and best practices for safe and effect
Autor:
Jason J Bergsbaken, Kim Noonan, Hope S. Rugo, Eun-Jeong Kim, David S. Ettinger, Dorothy A. Shead, Dwight D. Kloth, Sally Y. Barbour, Laura Boehnke Michaud, Charles L. Loprinzi, Philip J. Bierman, Ruth Lagman, Georgiana Ellis, John P. Timoney, Susan G. Urba, Michael Berger, Debra Brandt, Bridget Scullion, Victoria Maurer, Dawn E. Dolan, Miranda Hughes, Jonathan Aston, Barbara Todaro, Lee S. Schwartzberg, Cynthia X. Ma, Lisle Nabell, Eric Roeland, Steve Kirkegaard, Dean Lim
Publikováno v:
Journal of the National Comprehensive Cancer Network. 15:883-893
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antie
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 25(3)
Objective Denosumab is a monoclonal antibody used for prevention of skeletal related events in patients with bone metastasis from solid tumors and is administered every four weeks. In our practice, denosumab is often given at different frequencies mo
Autor:
Gary R, Morrow, Lee, Schwartzberg, Sally Y, Barbour, Gianluca, Ballinari, Michael D, Thorn, David, Cox
Publikováno v:
The Journal of Community and Supportive Oncology. 12:250-258
Patients who receive cancer chemotherapy are at risk for nausea and vomiting. The incidence and severity of these effects depend on the inherent emetogenic potential of the chemotherapeutic agents and their dosage and administration schedules, and pa
Autor:
Lida Nabati, Susan G. Urba, Steve Kirkegaard, Dwight D. Kloth, Dean Lim, Debra K. Armstrong, Michael Anne Markiewicz, Lisa Stucky-Marshal, Bob Bradbury, David S. Ettinger, Georgianna Ellis, Hope S. Rugo, Carli Nesheiwat, Philip J. Bierman, Sally Y. Barbour, Michael Berger, Barbara Todaro, Steven Sorscher, Mark G. Kris
Publikováno v:
Journal of the National Comprehensive Cancer Network. 7:572-595
Autor:
Sally Y. Barbour
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 10(4)
Chemotherapy-induced nausea and vomiting (CINV) is one of the most feared side effects of cancer treatment, despite the advances over the past decades. Corticosteroids have been shown to be effective in the management of CINV. These agents are usuall
Autor:
Michael A. Jantz, Pyng Lee, Prasoon Jain, G. Burkhard Mackensen, Gerard A. Silvestri, Momen M. Wahidi, Carla Lamb, Sally Y. Barbour
Publikováno v:
Chest. 140(5)
Background Optimal performance of bronchoscopy requires patient's comfort, physician's ease of execution, and minimal risk. There is currently a wide variation in the use of topical anesthesia, analgesia, and sedation during bronchoscopy. Methods A p